论文部分内容阅读
公司背景华北制药集团倍达有限公司是由亚洲最大的抗生素生产基地——华北制药集团有限责任公司与日本十大商社之一的日绵株式会社共同投资创建的合资企业,致力于半合成抗生素及其系列产品的生产经营和研制开发工作,是目前亚洲最大的半合成抗生素生产企业。倍达公司被列为国家重点工程“双加工程”,占地200亩,总投资5990万美元,其中中方66％,日方34％。倍达公司座落于中国河北省省会石家庄良村经济技术开发区内,生产环境整洁、优雅。公司拥有员工593人,全部具有高中以上文凭,其中高级职称人员有28人,中级职称人员有158人,具有计算机专业知识的技术人员56人,员工文化素养普遍较高。
Background of the company North China Pharmaceutical Group Beida Co., Ltd. is a joint venture established by North China Pharmaceutical Group Co., Ltd., Asia’s largest antibiotic production base, and Japan Mian Co., Ltd., one of the top 10 trading companies in Japan, to invest in semi-synthetic antibiotics. The production, operation, research and development of its series of products is currently the largest semi-synthetic antibiotic manufacturer in Asia. Beida Company was listed as the National Key Project “Double Plus Project”, covering an area of 200 mu, with a total investment of 59.9 million US dollars, of which 66% were from China and 34% from Japan. Beida Company is located in Liangcun Economic and Technological Development Zone, Shijiazhuang, capital of Hebei Province, China. The production environment is clean and elegant. The company has 593 employees, all with a high school diploma or above, including 28 senior professional titles, 158 intermediate professional titles, and 56 technical personnel with computer professional knowledge. The employees’ cultural literacy is generally higher.